Ticks are blood-sucking ectoparasite arthropods that suppress host immunity by secreting immunomodulatory molecules in their saliva. Here, compounds present in Rhipicephalus sanguineus tick saliva with immunomodulatory effects on DC differentiation, cytokine production, and costimulatory molecule expression were identified. R. sanguineus tick saliva inhibited IL-12p40 and TNF-α, while potentiating IL-10 cytokine production by bone marrow (BM)-derived DCs stimulated by Toll-like receptor (TLR)-2, -4, and -9 agonists. In order to identify the molecules responsible for these effects, we fractionated the saliva through microcon filtration and reversedphase high performance liquid chromatography (RP-HPLC) and tested each fraction for DC maturation. Fractions with proven effects were analyzed by micro-HPLC tandem mass spectrometry or competition ELISA assay. Thus, we identified for the first time in tick saliva, the purine nucleoside adenosine (Ado; concentration ~ 110 pmoles/µL) as a potent antiinflammatory salivary inhibitor of DC cytokine production. We also found prostaglandin-E 2 (PGE 2 ~ 100 nM) with comparable effects in modulating cytokine production by DCs. Both Ado and PGE 2 inhibited cytokine production by inducing cAMP-PKA signaling in DCs. Additionally, both Ado and PGE 2 were able to inhibit expression of CD40 in mature DCs. Finally, flow cytometry analysis revealed that PGE 2, but not Ado, is the differentiation inhibitor of BM-derived DCs. The presence of nonprotein molecules adenosine and PGE 2 in tick saliva indicates an important evolutionary mechanism used by ticks to subvert host immune cells and allow them to successfully complete their blood meal and life cycle.
Dendritic cells (DCs) are powerful initiators of innate and adaptive immune responses.
Ticks are blood-sucking ectoparasite arthropods that suppress host immunity by secreting immunomodulatory molecules in their saliva. Here, compounds present in Rhipicephalus sanguineus tick saliva with immunomodulatory effects on DC differentiation, cytokine production, and costimulatory molecule expression were identified. R. sanguineus tick saliva inhibited IL-12p40 and TNF-α, while potentiating IL-10 cytokine production by bone marrow (BM)-derived DCs stimulated by Toll-like receptor (TLR)-2, -4, and -9 agonists. In order to identify the molecules responsible for these effects, we fractionated the saliva through microcon filtration and reversedphase high performance liquid chromatography (RP-HPLC) and tested each fraction for DC maturation. Fractions with proven effects were analyzed by micro-HPLC tandem mass spectrometry or competition ELISA assay. Thus, we identified for the first time in tick saliva, the purine nucleoside adenosine (Ado; concentration ~ 110 pmoles/µL) as a potent antiinflammatory salivary inhibitor of DC cytokine production. We also found prostaglandin-E 2 (PGE 2 ~ 100 nM) with comparable effects in modulating cytokine production by DCs. Both Ado and PGE 2 inhibited cytokine production by inducing cAMP-PKA signaling in DCs. Additionally, both Ado and PGE 2 were able to inhibit expression of CD40 in mature DCs. Finally, flow cytometry analysis revealed that PGE 2, but not Ado, is the differentiation inhibitor of BM-derived DCs. The presence of nonprotein molecules adenosine and PGE 2 in tick saliva indicates an important evolutionary mechanism used by ticks to subvert host immune cells and allow them to successfully complete their blood meal and life cycle.
Ticks are phylogenetically distant from their hosts but, in general, these ectoparasites have developed, through their evolution, measures for adapting to host defense strategies. The most well studied approaches that ticks employ to evade host responses are the refined cocktails of proteic and non-protein molecules present in their saliva with anticlotting, antiinflammatory, or immunomodulatory activities. As a result, a number of authors have demonstrated the suppression of cell-and humoral-mediated immune responses upon in vitro assays as well as following experimental models of tick infestations or naturally infested hosts (1) (2) (3) (4) (5) (6) (7) (8) .
In the last four decades, many of these proteic and non-protein molecules have been characterized and their specific functions identified. To date, a diversity of proteic (e.g., chitinases, mucins, ixostatins, cystatins, defensins, hyaluronidases, Kunitz, lectins, and lipocalins) and non-protein molecules (e.g., prostaglandins and endocannabinoids) have been characterized (9) (10) (11) (12) (13) (14) . Regarding anti-tick immunity, molecules present in tick saliva have been associated with modulation of various steps of host immune responses. For example, Sialostatin L and PGE 2 , inhibit maturation of dendritic cells (DCs) and prevent antigen presentation (13, 15) ; DAP-36 and SALP15, inhibit T cell proliferation and activation (16, 17) ; ISL 929 and ISL 1373, reduce recruitment of neutrophils (18) ; IgG-binding proteins, theoretically decrease antibody functions (3, 19) ; ISAC, SALP-20, and OmCI, inhibit alternative and/or classical pathways of the complement system (20, 21) ; and EVASIN-1, -3 and -4, bind chemokines and hamper cell migration (22, 23) .
Despite the characterization of these molecules, most compounds in tick saliva thought to interfere in numerous other immunologic events described in the literature remain to be identified. In previous works, we have demonstrated the modulatory effects of saliva from Rhipicephalus sanguineus ticks on differentiation, migration, and maturation of DCs (24) (25) (26) . Despite our wealth of knowledge, the molecules responsible for such effects have not yet been elucidated. In this study, we have identified for the first time the purine nucleoside adenosine (Ado), isolated directly from tick saliva, as an inhibitor of production of pro-inflammatory IL-12p40 and TNF-α cytokines and stimulator of production of anti-inflammatory IL-10 by murine DCs activated with Toll-like receptor (TLR) agonists.
We have also identified prostaglandin-E 2 (PGE 2 ) in R. sanguineus tick saliva, which presented similar effects of Ado on cytokine production by DCs and additionally suppressed the differentiation of DCs from blood cell precursors. Our results also demonstrate that both, Ado and PGE 2 , exert their modulatory effects on cytokine production by inducing a common cAMP-PKA signaling pathway. Furthermore, both Ado and PGE 2 were able to inhibit expression of CD40 in mature DCs, and presented additive effects when administered together. Thus, the present report demonstrates the central involvement of tick salivary Ado and PGE 2 in modulation of the host inflammatory/immune responses.
Moreover, the data presented herein provide important insight to the evolution of host-tick interaction and provide a foundation for future pharmaceutical interventions that target nonprotein molecules used by ticks to permit their blood feeding.
Experimental Procedures
Experimental animals-Female C57BL/6 mice (6 to 10 weeks old) were purchased from Taconic Farms (Germantown, NY). Mice were bred and maintained at an American Association of Laboratory Animal Careaccredited facility at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. All experiments with mice were evaluated and approved by the Experimental Animal Ethics Committee of the National Institutes of Health. The experiments with dogs were evaluated and approved by the Ethics Committee on Animal Use of the School of Medicine of Ribeirão Preto (USP)/Brazil and are in line with the Guidelines for Animal Users as issued by the National Institute of Health. Saliva collection-R. sanguineus ticks were laboratory reared, as previously described by Ferreira and Silva (27) . To obtain engorged ticks for saliva collection, dogs (N = 10) were infested with 70 pairs of adult R. sanguineus ticks restricted by plastic feeding chambers fixed to their backs. The saliva collection procedure was performed in partially engorged female ticks (after 5-7 days of feeding) by inoculation of 10 μl of a 0.2% (v/v) solution of dopamine in phosphate-buffered saline, pH 7.4, into the haemocoele using a 12.7 × 0.33-mm needle (Becton-Dickinson, Franklyn Lakes, NJ). Saliva was harvested using a micropipette, kept on ice, pooled, filtered through a 0.22 μm pore filter (Costar-Corning Inc., Cambridge, MA), and stored at -70 o C for further use. Saliva protein concentration (~ 970 µg/mL) was determined by molecular sieving using absorbance at 280 nm. Separation of tick saliva fractions by microcon filtration-To determine the approximate mass of the active component(s) of R. sanguineus tick saliva, samples were initially fractionated by microcon centrifugal filters (Millipore, Oliveira 3 Bedford, MA) following manufacturer's instructions to provide fractions with apparent molecular weights of < 5 and 5-100 kDa. (28) , with modifications (13) . Briefly, BM cells from femurs of C57BL/6 mice were cultured in complete medium (RPMI 1640 medium with 10% heatinactivated FBS, 2 mM L-glutamine, 100 U/ mL penicillin, 100 µg/mL streptomycin, 0.05 mM 2-ME) and 20 ng/mL GM-CSF. At day 0, cells were seeded at 10 6 per 100-mm petri dish (Falcon 1029 plates; BD Discovery Labware, Bedford, MA) in 10 mL of medium. At days 3 and 6, another 10 mL of complete medium containing 20 ng/mL GM-CSF was added to the plates. The differentiated cells were harvested on days 6-7 of culture for flow cytometry analysis and cytokine production assays. Flow cytometry-For experiments on the effect of saliva on DC differentiation, BM-derived DCs were cultured as described above in the presence of the indicated concentrations of tick saliva or saliva fractions and incubated with fluorochrome labeled antibodies. Percentage of CD11c + cells (DC-restricted marker for mice) and CD11b + cells (a myeloid cell marker) was evaluated.
In another set of experiments described below, DCs were also collected to evaluate the expression of co-and stimulatory molecule expression. To that end, cells were stained with fluorochrome labeled antibodies against CD11c, CD40, CD86, and MHC class II (I-A/I-E) molecules. Data were acquired using a FACSCalibur (BD Immunocytometry Systems) with CellQuest (BD Biosciences) and analyzed with FlowJo software (Tree Star Inc., Ashland, OR). Cytokine production assay-Six-to 7-day cultured BM-derived DCs were gently collected, washed twice, and resuspended at 10 6 cells/mL in complete medium. Cells were then cultured at 10 5 cells/well in round-bottom 96-well cluster plates (Costar, Cambridge, MA) and incubated, depending on the experiments, with medium, saliva, saliva filtrates or saliva fractions for 30 minutes before addition of TLR-2 (PGN, 10 µg/mL), TLR-4 (LPS, 100 ng/mL), or TLR-9 (CpG ODN-1826, 0.15 µM) ligands. Following overnight incubation (18 hrs) at 37°C and 5% CO 2 , cell-free supernatants were collected and levels of IL-12p40, TNF-α, and IL-10 determined. HPLC procedures-R. sanguineus saliva (1.5 mL) was centrifuged through a YM-5 microcon device (Millipore, Bedford, MA). The filtered  5 kDa fraction was submitted to a reversedphase HPLC on a C18 column (4.3 × 150 mm; ThermoSeparation Products, Riviera Beach, FL) perfused at 0.5 mL/min using a CM-4100 pump (Thermo Separation Products, Riviera Beach, FL).The eluent was monitored at 220-500 nm using a diode array detector (model SPD M10AV, Shimadzu, Columbia, MD) A gradient of 80-minutes duration from 5 to 80% acetonitrile in water, containing 0.1% trifluoroacetic acid, was imposed after injection of the sample. Aliquots of these fractions were dried in 96-well plates and tested for cytokine inhibitory activity and co-and stimulatory molecule expression on DCs at dilutions compatible for those employed for crude saliva. Mass spectrometry-Selected fractions from the RP-HPLC experiment were analysed by mass spectrometry by direct injection (5 µl) of the fractions into a Thermo-Finnigan LCQ Deca XP Ion Trap Mass Spectrometer, through an ion-spray interface supplied with a continuous flow of 50% methanol in water containing 0.1% acetic acid. Fragmentation of selected ions was performed with 30% maximum intensity. Calibration curves using commercial adenosine were performed in order to estimate salivary adenosine concentration. PGE 2 concentration in saliva, filtrate, and fractions-The amount of PGE 2 in saliva samples as well as its concentration in the filtrate and fractions used for cell culture was determined by competition ELISA kit (R&D Systems, Minneapolis, MN), according to manufacturer's instructions. The detection limit for the assay was (~ 42 pM).
Ado determination in  5 kDa filtered saliva
fractions-The amount of Ado in saliva fractions used for cell culture was determined by mass spectrometry of the molecular ions present in fraction 11 (F11). To further confirm functional activity of Ado in the saliva, we also carried out experiments incubating the saliva or saliva fractions with ADA (3.0 U for 1 hr at 25 o C) and testing each one for maturation of DCs. Measurement of cAMP in DCs-DCs exposed to saliva or saliva fractions were used to measure production of intracellular levels of cAMP. Cells (10 6 ) were seeded in 96-well round-bottom tissue culture plates and treated with saliva or saliva fractions for 15 minutes. Cells were then lysed with 0.1 M HCl/0.1% Triton X-100, and intracellular cAMP was measured by commercial enzyme immunoassay kits (Cayman Chemicals, Ann Arbor, MI) according to manufacturer's instructions. Data analysis-Data are shown as mean ± SEM. Statistical differences were analyzed by ANOVA followed by Tukey-Kramer post-hoc analysis test (INSTAT software; GraphPad, San Diego, CA). A P value of 0.05 or less was considered statistically significant.
RESULTS

R. sanguineus
tick saliva inhibits production of IL-12p40 and TNF-α while increasing IL-10 cytokine production by DCs triggered by different TLR agonists-We first tested whether R. sanguineus tick saliva could modulate cytokine production by DCs matured with PGN, LPS, and CpG (TLR-2, -4, and -9 agonists, respectively). As expected, treatment of DCs for 18 hrs with these TLR agonists increased the levels of IL-12p40 and TNF-α (Fig. 1A, B) ; however, when cell cultures were pre-incubated with whole saliva (dilution 1:20 v:v) for 30 minutes, significant inhibition (P < 0.05) of PGN-, LPS-, or CPG-induced IL12p40 and TNF-α production by DCs was seen (Fig. 1A, B) . Conversely, pre-incubation with saliva (1:20 v:v) enhanced PGN-, LPS-, or CPG-induced IL-10 production by these cells (Fig. 1C) (P < 0.05). Levels of IL-12p40, TNF-α, and IL-10 were not changed in cultures incubated with saliva alone, suggesting that saliva lacks either contaminants or TLR ligands (Fig. 1) .
To determine the closest molecular weight (MW) of the component(s) in the saliva responsible for modulation of cytokine production in DCs, 500 µL of saliva were sequentially centrifuged through microcon devices. The filtrate (equivalent volume to saliva diluted 1:20) with MW lower than 5 kDa or between 5 and 100 kDa were tested in the LPS-induced cytokine production assay ( Fig.  1D-F ). The data indicate that when LPS-treated DCs were pre-incubated with the fraction of saliva containing molecules with MW lower than 5 kDa their competence to produce IL12p40 and TNF-α cytokines was repressed (P < 0.05). The inhibition was similar to that seen with non-fractionated saliva (Fig. 1D, E) . Saliva fractions containing molecules with MW lower than 5 kDa also additively up-regulated production of IL-10 by LPS-treated DCs (Fig.  1F) . Fractions containing molecules with MW between 5 and 100 kDa did not modify production of these cytokines (Fig. 1D-F) .
Analysis of tick saliva fractionated by RP-HPLC indicates that it contains two active components lower than 5 kDa-To identify the component(s) responsible for the effects of tick saliva on DCs, we further fractionated 1.5 mL of YM-5 filtrate by reverse-phase HPLC and tested the fractions for production of the cytokines in LPS-treated DCs. Fig. 2A depicts an HPLC fingerprint of the 80 fractions  5 kDa saliva filtrate at the absorbance of 220 nm. The 80 fractions were then assembled into 10 pools (comprising eight fractions each) that were tested independently for production of IL12p40 and TNF-α on DCs stimulated with LPS. When DCs were pre-incubated for 30 minutes with pools 2 (containing fractions 9-16) and 7 (containing fractions 49-56), but not the remaining pools, LPS-induced IL-12p40 and TNF-α production was diminished (Fig. 2B, C) . Next, we tested individually each of the fractions of pools 2 and 7 in a similar assay. As shown in Fig. 2 (D, E and F (Fig. 3A) . The mass spectra of the molecular ions present in F11 were informative and analogous to Ado (Fig 3B) . Fragmentation of the 268 mass ion leads to production of an ion having m/z 136, as expected for adenine (55) (Fig. 3C) . Finally, MS showed the presence of approximately 110 pmoles/µL of Ado in F11 (Fig. 3D) .
It has been demonstrated by Sá-Nunes and collaborators that PGE 2 was present at the end of the gradient of a micro-HPLC from Ixodes scapularis saliva (13) . Because this eicosanoid had already been also described in the saliva of R. sanguineus ticks (28) , as well as in the saliva of many other tick species (29-31), we asked whether F51 from R. sanguineus tick salivaalso found at the end of a micro-HPLC gradient-could be PGE 2 . Using a PGE 2 -specific competition ELISA, we found that saliva,  5 kDa saliva filtrate, and F51 indeed contained PGE 2 , and that the concentration of both samples was ~ 100 nM (Fig. 3E) .
F11 loses activity on DCs when exposed to the enzyme ADA-To evaluate whether the Ado identified in F11 would have similar activity to synthetic Ado, we treated saliva or F11 with ADA, which degrades Ado into inosine, and tested it on DCs. As previously shown, R. sanguineus saliva (dilution 1:20) presented a potent inhibitory effect on LPS-induced production of IL-12p40 and TNF-α by DCs. When this saliva was treated with ADA, its effects were partially impaired (P < 0.05) (Fig.  4A, B) . Furthermore, when F11 was treated with ADA, this fraction entirely lost its cytokine modulating outcome (P < 0.05) (Fig.  4A, B) . Intriguingly, while F11 treated with ADA also lost its ability to enhance LPSinduced production of IL-10 (P < 0.05), this did not happen to ADA-treated saliva (Fig. 4C) . The rationale for this is unknown; however, as saliva also contains PGE 2 , possibly this component alone is enough to sustain production of IL-10 independently of Ado. Indeed, when DCs were pre-cultured with F51 (which contains PGE 2 ), a similar enhancement of IL-10 production induced by LPS was seen in comparison with DCs pre-cultured with total saliva (Fig. 4C) . As expected, ADA treatment did not alter the effect of F51 (which contains PGE 2 , not Ado) on production of cytokines by LPS-stimulated DCs (Fig. 4A, B) .
It has been shown that inosine is able to modulate the effect of IL-12 and TNF-α of murine macrophages and splenic cells (32) . To prove that inosine generated in the above experiment by the action of Ado degradation does not exert modulatory effects on murine DCs, we pre-treated DCs with inosine and stimulated them overnight with LPS. The results showed that even at a concentration of 100 µM, standard inosine was not able to modulate production of IL-12 and TNF-α by murine LPS-matured DCs (data not shown).
F11 and F51 from R. sanguineus saliva cooperate in the amplification of cAMP-PKA signaling-Because initiation of the signaling pathway used by Ado and PGE 2 to modulate cytokine is via production of cAMP (33, 34), we evaluated whether F11 and F51 from R. sanguineus tick saliva increases production of cAMP in DCs. As depicted in Fig. 5A , when F11 or F51 was added separately, it induced a significant (P < 0.05) production of cAMP. Further, when added together, they showed an additive effect -comparable to whole salivaon the amplification of cAMP (Fig. 5A) . As a positive control, DCs were also incubated with forskolin, a drug known to induce cAMP production in different cell types, and massive production (P < 0.05) of cAMP was seen (Fig.  5A) .
A downstream intracellular molecule activated by cAMP is the protein kinase A (PKA), an essential enzyme for cell signaling, that among other effects plays an important role in modulation of cytokines induced by both Ado and PGE 2 (33) (34) (35) . Having shown that F11 and F51 induce cAMP production, we further evaluated whether these fractions had their immunosuppressive effects blocked by H-89, a PKA inhibitor. To answer this question, DCs were treated with H-89 (3 µM), and the ability of F11 and F51 to modulate LPS-induced IL12p40, TNF-α, and IL-10 cytokine production was tested. Our results demonstrate that H-89 reversed significantly (P < 0.05) but not completely the inhibitory effect of F11and F51 (Fig. 5B-D) . When DCs were pre-incubated with H-89, the competence of F11 or F51 alone or F11 plus F51 to inhibit IL-12p40 and TNF-α production stimulated by LPS was significantly reversed (Fig. 5B, C) . Further, production of IL-10 induced by F11 or F51 in the presence of LPS was completely restored after H-89 treatment, while IL-10 production induced by F11 plus F51 was restored only partially (Fig.  5D) . No difference in cytokine production was seen when H-89 was added alone to DCs stimulated by LPS (data not shown). These results suggest F11 and F51 modulate only partially LPS-induced cytokine production in DCs by cooperating in amplification of cAMP-PKA signaling. increased the intensity of expression of CD40 and CD86 (Fig. 6A, B) . When DC cultures were pre-incubated with whole saliva for 30 minutes at 1:20 dilution, significant inhibition (P < 0.05) of the percentage of PGN-, LPS-, or CPG-induced CD40 (Fig. 6A) and CD86 (Fig.  6B ) expression was observed. Pre-incubation with the filtrate of 0-5 kDa but not 5-100 kDa also inhibited LPS-induced expression of CD40 and CD86 (Fig. 6C,D) . To further investigate whether the effects of saliva or filtrate are mediated by F11, F51, or both, DCs were pre-incubated with F11, F51 or F11 plus F51 for 30 minutes and subsequently stimulated with LPS, and expression of CD40 and CD86 molecules was evaluated 18 hrs later. As shown in Fig. 6E , pre-incubation with F11 or F51 inhibited (P < 0.05) LPS-induced expression of CD40. Moreover, F11 and F51 demonstrated an additive inhibitory effect (Fig. 6E) . On the other hand, F11, F51 or F11 plus F51 did not affect expression of CD86 molecules (data not shown). We attempted to analyze the different fractions from the filtrate of 0-5 kDa on CD86 expression, but following F11 and F51, no fractions were found with those properties (data not shown). These findings suggest that molecules present in saliva or 0-5 kDa filtrate only suppress LPS-induced CD86 expression when these compounds act together on DCs. Further studies must be done to characterize which molecules can account for inhibition of expression of CD86 by saliva.
F11 and F51 inhibit LPS-induced CD40 expression in DCs-
F51 impairs differentiation of BM-derived DCs-
A previous work demonstrated that saliva from R. sanguineus ticks inhibits differentiation of DCs (24) . To determine whether saliva-impaired differentiation of DCs was caused by the presence of saliva Ado, PGE 2 , or both, BM-derived DCs were developed with GM-CSF in the presence of saliva, F11, F51, or both. Within 6-7 days of differentiation, the percentage of CD11c +
CD11b
+ was determined by flow cytometry. Fig. 7A and B show that R. sanguineus saliva significantly inhibited differentiation of BM precursors into CD11c + /CD11b + DCs (P < 0.05). Similarly to saliva, when F51 was added to cultures there was a significant inhibition of DC differentiation (P < 0.05). F11 alone or together to F51 did not impair DC differentiation (Fig. 7A, B) . More important, even when tested in a high concentration (100 µM), F11 did not hamper DC differentiation (data not shown).
DISCUSSION
The discovery of new molecules produced by parasites has become an important venue of many researchers who are trying to comprehend host-parasite interactions. This tendency is growing because information about the biological activities, structure, ligandbinding affinities, and concentration of these molecules open to a greater extent the array of possibilities for find out how these organisms evade hemostatic, inflammatory, and immunologic host responses.
Our group has worked to identify the molecules present in the saliva of the dog tick R. sanguineus with modulatory effects on diverse immune cells. Here, we indentify for the first time in tick saliva the nucleoside Ado as a potent immunosuppressor of DCs. This report also demonstrates PGE 2 from saliva of R. sanguineus ticks with comparable modulatory effects. Our data demonstrate clearly that both Ado and PGE 2 cooperate in modulating the production of IL-12p40, TNF-α, and IL-10 cytokines and inhibiting expression of the stimulatory molecule CD40 on DCs activated with TLR agonists. The additive effect induced by Ado and PGE 2 probably results from the capacity of both molecules to cooperate in induction of cAMP-PKA signaling in DCs.
First we demonstrated that salivary molecules from R. sanguineus ticks with MW below 5 kDa downregulates production of IL12p40 and TNF-α and upregulates production of IL-10 by DCs stimulated with TLR-2, -4, and -9 agonists. These findings are of great interest, as IL-12p40 and TNF-α can induce functional maturation of DCs and could selectively stimulate their ability to induce Th1-type responses against ticks and tick-borne pathogens, while IL-10 is well known as an immunosuppressive cytokine (36) (37) (38) .
Using microcon filtration and reversephase HPLC MS/MS, we found the nucleoside Ado in the saliva of R. sanguineus ticks. The saliva fraction that contained Ado presented a relevant effect on the biology of DCs, which may have important implications for our understanding of tick-host interactions. It is known that Ado is an endogenous purine nucleoside that modulates a wide variety of immunologic functions in antigen-presenting cells (39) (40) (41) (42) . It impairs TNF-α-and IL-12p40-mediated responses to LPS in human and murine DCs while enhancing production of 44) . Ado also suppresses production of IL-12 and TNF-α in monocytes and macrophages (33, (45) (46) . In agreement with our results, others have shown that Adoinduced inhibition of TNF-α production by macrophages is not restricted to TLR-4-mediated activation, because Ado also downmodulates TNF-α production when cells are activated by TLR-2, -3, -7, and -9 agonists (47).
Besides blocking LPS-induced TNF- production, Ado markedly induces heme oxygenase 1 (HO-1) in inflamed tissues (48) . This is noteworthy because ticks are blood feeders and abundant quantities of heme, a potent pro-oxidant and pro-inflammatory agent, are probably released at the tick feeding site. HO-1 removes heme and, further, generates three metabolites-carbon monoxide (CO), ferrous iron, and biliverdin-all of which have an immune protective effect (49) . A positive feedback loop exists among Ado, HO-1, and CO and resolves the inflammatory response (48) . Blocking of HO-1 by RNA interference abrogates the effects of adenosine on TNF- and HO-1 in macrophages. Another venue in which tick salivary Ado may disrupt host defenses is the migration of phagocytic cells to the site of tissue damage caused by tick feeding. Signaling by means of purinergic receptors has been recently shown to be essential for chemotaxis of macrophages in a gradient of C5a (50) . This requires sequential hydrolysis of nucleotides ending in Ado, and an excess of Ado provided by tick saliva may disrupt the sequence of events resulting in correct chemotactic navigation.
Components from tick saliva and salivary glands, including Ado, inhibit the biology of not only DCs but that of many other immune cells including neutrophils, mast cells, NK cells, T and B cells (42, (51) (52) (53) (54) (55) . This can be particularly relevant, as the tick Ado identified in this work could be responsible for the effects described above. Further studies must be performed to test this hypothesis. Furthermore, Ado possibly has an important role in evolution as an evasion mechanism for blood-sucking parasites. Indeed, salivary glands of other classes of hematophagous arthropods, notably sand flies Phlebotomus argentipes and Phlebotomus papatasi (55, 56) , also produce Ado; however, it has not yet been tested for its immunomodulatory properties.
We found another fraction of R. sanguineus tick saliva that had a modulatory effect on cytokine production by DCs. Using a competition ELISA we ascertained that this fraction contained PGE 2 in a considerable amount. Similarly to data described here, saliva of many tick species has been shown to contain PGE 2 ; moreover, it has been associated with the saliva effect on suppression of host immune responses (13, (57) (58) . As we reported with PGE 2 of the saliva, synthetic PGE 2 inhibits the ability of monocytes, macrophages, and DCs to secrete cytokines such as IL-12 and TNF-α (59-63) and may shift the balance in favor of a Th2 immune response. PGE 2 can also act directly on T cells by impairing production of IL-2 and IFN-γ (64), which also could induce a Th2-type response. In support of our findings, PGE 2 isolated from I. scapularis saliva is the major inhibitor of IL-12 and TNF-α induced by LPS-stimulated DCs (13). However, PGE 2 concentrations in I. scapularis saliva were 10-to 100-fold higher than that found in our study (Sá-Nunes, personal communication). This might explain why R. sanguineus saliva needs an additional molecule -Ado -to reach modulatory activities in pharmacological levels.
Related to Ado and PGE 2 -induced intracellular cascade, we observed as expected that both molecules in the saliva fractions were able to induce production of cAMP by DCs; furthermore, when combined they showed an additive effect. Interestingly, Ado or PGE 2 used individually or in combination lose their modulatory activity when DCs are preincubated with H-89, a PKA inhibitor. This result is important because we demonstrate that both molecules affect production of cytokines by DCs by a common signal transduction pathway, linking increased production of cAMP and PKA activation. At the same line, it was demonstrated that Ado and PGE 2 produced by human regulatory T cells have additive effects in downregulating functions of immune cells through intracellular cAMP-PKA signaling (65) . It is essential to mention that the treatment of DCs with the PKA inhibitor did not restore completely the production of IL12p40 and TNF-α, suggesting that Ado and PGE 2 may modulate DCs via signaling pathways other than cAMP-PKA. Our data are in accordance with those of Vassiliou, et al. (60) , who reported that inhibition of LPSstimulated TNF-α production in murine DCs by PGE 2 was only partially prevented by the PKA inhibitor H-89. In support of this possibility, a recent work has revealed that alternative cAMP-binding targets, such as the guanine nucleotide exchange protein (Epac-1), can be also responsible for inhibition of TNF-α cytokine production in DCs (66) .
Enhancement of co-and stimulatory molecules on DCs' surface is fundamental to induce a proper T cell response. Here, we demonstrate that tick saliva suppressed expression of CD40 and CD86 in DCs. Blocking binding of CD40 with its ligand CD40L (CD154) prevents T cell dependent antibody production and reduces CD4 + T cell priming and expansion, which can impair the development of a protective host response to parasitic infections (67) (68) (69) (70) . Indeed, it was shown that the blockage of CD40-CD154 and CD86-CD28 interactions could result in T cell anergy and high IL-10 production (71). This aspect is relevant because the modulatory effect on cytokine production, together with reduction in expression of CD40 and CD86, could be an important "double-escape" mechanism used by ticks to induce regulatory T cells, T cell anergy, or to inhibit antigen presentation. These host conditions could probably help blood-feeding arthropods to complete their meal and, moreover, could facilitate transmission of vector-borne pathogens during the parasitic stage. Interestingly, only CD40 but not CD86 expression was downregulated by saliva fractions containing Ado and/or PGE 2 . The explanation for why crude tick saliva and saliva filtrate impair CD86 expression but saliva fractions individually do not is unknown. Possibly a combination of saliva fractions is required. Additional studies must be done to identify these molecules.
Finally, we showed that PGE 2 from saliva dramatically inhibits differentiation of BMderived DCs. These results are in accordance with previous results showing that PGE 2 inhibits differentiation of murine and human DCs (72, 73) . The effect of R. sanguineus saliva in inhibiting differentiation of DCs was previously demonstrated by Cavassani et al. (24) ; however, only now has the molecule responsible for this effect been identified. Saliva fractions that contain Ado showed no effect on DC differentiation, possibly explained by work demonstrating that Ado is related to macrophage inhibition and DC differentiation in human (74, 75) but not in murine (76) Because IMBF and JMCR are government employees and this is a government work, the work is in the public domain in the United States. Notwithstanding any other agreements, the NIH reserves the right to provide the work to PubMedCentral for display and use by the public, and PubMedCentral may tag or modify the work consistent with its customary practices. You can establish rights outside of the U.S. subject to a government use license.

The abbreviations used are: ADA, Ado deaminase; Ado, adenosine; BM, bone marrow; DCs, dendritic cells; Filt, filtrate; HO-1, heme oxygenase 1; RP-HPLC, reversed-phase high performance liquid chromatography; MS, mass spectrometry; MS/MS tandem MS; MW, molecular weight; PGE 2 , prostaglandin-E 2 ; PGN, peptidoglycan; PKA, protein kinase A; TLR, Toll-like receptor. Fig. 1 . Tick saliva modulates cytokine production induced by diverse Toll-like ligands by use of molecules with MW< 5 kDa. DCs from C57BL/6 mice were produced from BM cells cultured with GM-CSF (20 ng/mL) for 6-7 days. Next, cells were washed and pre-incubated with medium (-), saliva (Sal; dilution 1:20) (A-C) or saliva (1:20) and saliva filtrates (filtrates < 5 kDa or 5-100 kDa (1:20)) (D-F). After 30 minutes, cells were stimulated overnight with TLR-2 (PGN; 10 µg/mL), TLR-4 (LPS, 100 ng/mL) and TLR-9 (CPG, 150 nM) ligands. After 18 hrs of incubation, cytokine levels in culture supernatants were measured by ELISA. The results are expressed as the mean  standard error of the mean (SEM) obtained from one of three independent experiments performed in triplicate (N = 3). *: P < 0.05 vs. respective LPS, CPG, and PGN groups without saliva or saliva filtrates. DCs from C57BL/6 mice were produced from BM cells cultured with GM-CSF (20 ng/mL) for 6-7 days. To isolate the molecules from the 5 kDa saliva filtrate related to DC modulation, saliva was filtered using an YM-5 (cut-off 5,000 Da) membrane and the filtrate was fractionated in 80 fractions by reverse-phase HPLC using the conditions described in Experimental Procedures. An HPLC chromatogram of the 5 kDa filtrate at 220 nm is demonstrated in A. B and C demonstrate by ELISA the production of IL-12p40 and TNF-α from the supernatant of DCs that were pre-incubated with different pools (pools containing eight fractions each, according to the eluting time, successively) from the separated filtrate and 30 minutes later stimulated for 18 hrs with LPS (100 ng/mL). D-G show production of IL-12p40 and TNF-α from the supernatant of DCs pre-incubated with fractions 9-16 (D,E) and 49-56 (F,G), for 30 minutes and subsequently stimulated for 18 hrs with LPS (100 ng/mL). Arrows indicate the pools and the isolated fractions with strongest inhibitory effect for each assay. Results are expressed as the mean  SEM obtained from one of two independent experiments performed in triplicate (N = 3). 
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